Skip to main content

Table 3 HOMA-IR in relation to metabolic syndrome (ATPIII) and the number of metabolic syndrome components in patients with manifest arterial disease

From: Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. The SMART study

n = 2611   N HOMA-IR QUICKI p-value
Metabolic syndrome no 1478 2.1 ± 1.4 0.28 ± 0.05 < 0.001
  yes 1053 3.7 ± 2.5 0.24 ± 0.04  
Metabolic syndrome components 0 137 1.4 ± 0.7 0.31 ± 0.05 < 0.001
  1 547 1.8 ± 1.2 0.30 ± 0.06  
  2 794 2.4 ± 1.5 0.27 ± 0.05  
  3 573 3.1 ± 1.8 0.25 ± 0.04  
  4 366 4.0 ± 2.6 0.23 ± 0.03  
  5 114 5.6 ± 3.6 0.22 ± 0.03